TITLE

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018

AUTHOR(S)

Brieger, David; Amerena, John; Attia, John R.; Bajorek, Beata; Chan, Kim H.; Connell, Cia; Freedman, Ben; Ferguson, Caleb; Hall, Tanya; Haqqani, Haris M.; Hendriks, Jeroen; Hespe, Charlotte M.; Hung, Joseph; Kalman, Jonathan M.; Sanders, Prashanthan; Worthington, John; Yan, Tristan; Zwar, Nicholas A.

PUB. DATE

October 2018

SOURCE

Medical Journal of Australia;10/15/2018, Vol. 209 Issue 8, p356

SOURCE TYPE

Academic Journal

DOC. TYPE

journal article

ABSTRACT

Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are continually evolving and care for patients requires confidence in integrating these new developments into practice. These clinical practice guidelines will assist Australian practitioners in the diagnosis and management of adult patients with AF. Main recommendations: These guidelines provide advice on the standardised assessment and management of patients with atrial fibrillation regarding: screening, prevention and diagnostic work-up; acute and chronic arrhythmia management with antiarrhythmic therapy and percutaneous and surgical ablative therapies; stroke prevention and optimal use of anticoagulants; and integrated multidisciplinary care. Changes in management as a result of the guideline: Opportunistic screening in the clinic or community is recommended for patients over 65 years of age. The importance of deciding between a rate and rhythm control strategy at the time of diagnosis and periodically thereafter is highlighted. β-Blockers or non-dihydropyridine calcium channel antagonists remain the first line choice for acute and chronic rate control. Cardioversion remains first line choice for acute rhythm control when clinically indicated. Flecainide is preferable to amiodarone for acute and chronic rhythm control. Failure of rate or rhythm control should prompt consideration of percutaneous or surgical ablation. The sexless CHA2DS2-VA score is recommended to assess stroke risk, which standardises thresholds across men and women; anticoagulation is not recommended for a score of 0, and is recommended for a score of ≥ 2. If anticoagulation is indicated, non-vitamin K oral anticoagulants are recommended in preference to warfarin. An integrated care approach should be adopted, delivered by multidisciplinary teams, including patient education and the use of eHealth tools and resources where available. Regular monitoring and feedback of risk factor control, treatment adherence and persistence should occur.

ACCESSION #

132373494

 

Related Articles

• Heartbeat: Focus on atrial fibrillation. Otto, Catherine M. // Heart;Jun2015, Vol. 101 Issue 11, p823 

  The article focuses on Atrial fibrillation (AF), which leads to irregular heart rate and reduced cardiac output in individuals. It states that Atrial fibrillation is associated with increased number of annual stroke risk, and discusses various factors which determine annual stroke risk including...

• Cryoballoon ablation for pulmonary vein isolation in patients with atrial fibrillation: preliminary results using novel short-tip cryoballoon. Koektuerk, Buelent; Yorgun, Hikmet; Koektuerk, Oezlem; Turan, Cem; Aksoy, Muhammet; Turan, Ramazan; Gorr, Eduard; Bansmann, Paul; Hoppe, Christian; Horlitz, Marc; Turan, Cem H; Aksoy, Muhammet Necati Murat; Turan, Ramazan G; Bansmann, Paul M // Journal of Interventional Cardiac Electrophysiology;Oct2016, Vol. 47 Issue 1, p91 

  Purpose: In this study, we aimed to report our preliminary experience regarding the impact of the novel short-tip (ST) cryoballoon (CB) on procedural efficacy and signal quality during pulmonary vein (PV) isolation for both paroxysmal and persistent atrial...

• Changes in left ventricular filling parameters following catheter ablation of atrial fibrillation. Krezowski, Joseph; Wilson, Brent; McGann, Christopher; Marrouche, Nassir; Akoum, Nazem; Krezowski, Joseph T; Wilson, Brent D; McGann, Christopher J; Marrouche, Nassir F // Journal of Interventional Cardiac Electrophysiology;Oct2016, Vol. 47 Issue 1, p83 

  Background: Atrial fibrillation (AF) is common in the setting of abnormal ventricular relaxation. We evaluated the association between ventricular relaxation grade and atrial fibrosis and examined the change in left ventricular filling parameters following catheter...

• A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: comparisons of sympathetic activity and left atrial size. Akutsu, Yasushi; Kaneko, Kyouichi; Kodama, Yusuke; Miyoshi, Fumito; Li, Hui-Ling; Watanabe, Norikazu; Asano, Taku; Tanno, Kaoru; Suyama, Jumpei; Namiki, Atsuo; Gokan, Takehiko; Kobayashi, Youichi // Journal of Interventional Cardiac Electrophysiology;Nov2013, Vol. 38 Issue 2, p79 

  Purpose: Development of atrial fibrillation (AF) is complexly associated with electrical and structural remodeling and other factors every stage of AF development. We hypothesized that P wave electrocardiography with an elevated brain natriuretic peptide (BNP) level would be associated with the...

• Images in cardiology: Exercise induced widening of the QRS complex in a patient on flecainide Turner, N.; Thwaites, B.C. // Heart;Apr2001, Vol. 85 Issue 4, p423 

  The article focuses on the toxic effect of flecainide to widen QRS complex and induce repolarisation abnormalities on exercise tests patients with atrial fibrillation. It states that the flecainide causes inhibition of the sodium channel, depressing the slope of the action potential, and widens...

• Best Practices in the Diagnosis and Treatment of Atrial Fibrillation. Cunningham, Muriel; Heck, Patrick; Linker, Nicholas; Linton, Nick // MD Conference Express;Oct2015, Vol. 15 Issue 28, p23 

  Treatment of patients with atrial fibrillation should be customized for each individual. Embolic and bleeding risk should be assessed when anticoagulating these patients to determine the optimal therapeutic approach. Recent evidence has shown that lifestyle modifications such as weight loss and...

• Listening for silent killers.  // South Asian Post;11/28/2013, p8 

  The article reports on the effort of Canadian cardiologist Jeff Healey to find new diagnostic procedures and treatment for atrial fibrillation (AF), a condition which features arrhythmia or irregular heartbeat, which has been found to be a cause of stroke in Canada.

• Overview of pathophysiology and management of AF. Banner, Davina; Lauck, Sandra // British Journal of Cardiac Nursing;May2013, Vol. 8 Issue 5, p241 

  Atrial fibrillation (AF) is a common supraventricular arrhythmia associated with uncoordinated and irregular atrial activity. It significantly affects morbidity and mortality by escalating the risk of thromboembolic phenomena and haemodynamic compromise. AF is associated with high health-care...

• Predicting and Treating AFib in Women.  // Women's Health Advisor;Jun2013, Vol. 17 Issue 6, p3 

  The article offers information related to the problem of Atrial fibrillation (AFib), an irregular heart rhythm that begins in the atria, in women. It discusses the symptoms of AFib in women. It also reflects on the treatment methodologies to prevent AFib recurrences such as antiarrhythmic...

Read the Article